Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools

Neurochemistry International

Volumn 33, Issue 5, 1998, Pages 459-466

  Page, Guylène ^a   Chalon, Sylvie ^b   Barrier, Laurence ^c   Piriou, Alain ^a,c   Huguet, François ^a,c  

^a UPRES EA 1223   (France)

^b INSERM   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; BRAIN MONOAMINE; DOPAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; NISOXETINE; RESERPINE; TETRABENAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0031774002     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00050-3     Document Type: Article

References (43)

1. Amara, S., Kuhar, M., 1993. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16, 73-93.
2. Benfield, P., Heel, R.C., Lewis, S.P., 1986. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32, 481-508.
3. Blakely, R., De Felice, L.J., Hartzell, H.C., 1994. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196, 263-281.
4. 3H]-GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. Eur. J. Pharmacol. 126, 211-222.
5. Bradford, M.N., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 76, 248-254.
6. Breese, G.R., Traylor, T.D., 1971. Effect of 6-hydroxydopamine on 7brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 174, 413-420.
7. Emond, P., Garreau, L., Chalon, S., Boazi, M., Caillet, M., Bricard, J., Frangin, Y., Mauclaire, L., Besnard, J.C., Guilloteau, D., 1997. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4′-iodophenyl) nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 40, 1366-1372.
8. Gerlach, M., Riederer, P., 1996. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm. 103, 987-1041.
9. Giros, B., El Mestikawy, S., Bertrand, L., Caron, M., 1991. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154.
10. Glowinski, J., Iversen, L.L., 1966. Regional studies of catecholamines in rat brain. J. Neurochem. 13, 655-663.
11. Henry, J.P., Gasnier, B., Roisin, M.P., Isambert, M.F., Scherman, D., 1987. Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane. Ann. N.Y. Acad. Sci. 493, 194-206.
12. Henry, J.P., Scherman, D., 1989. Radioligands of the vesicular monoamine transporter and their use as markers of the monoamine storage vesicles. Biochem. Pharmacol. 38, 2395-2404.
13. Hofstee, B.H.T., 1952. On the evaluation of the constants Vmax and Km in enzyme reactions. Sci. 166, 329-331.
14. 3H-dopamine into synaptosomes from rat striatum. Molecular Pharmacol. 10, 746-758.
15. Horn, A.S., 1979. Characteristics of dopamine uptake. In: Horn, A.S., Korf, J., Westerink, B.H.C. (Eds.), The Neurobiology of Dopamine. Academic Press, New York, pp. 217-235.
16. Horn, A.S., 1990. Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 34, 387-400.
17. Huff, R.A., Vaughan, R.A., Kuhar, M.J., Uhl, G.R., 1997. Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax. J. Neurochem. 68, 225-232.
18. 3H] Serotonin uptake by cocaine: comparison between chopped tissue slices and synaptosomes. Life Sci. 50, 541-547.
19. Jaber, M., Jones, S., Giros, B., Caron, M.G., 1997. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disorders 12, 629-633.
20. 3H] GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex. J. Neurochem. 46, 1272-1276.
21. Kelly, R.B., 1993. Storage and release of neurotransmitters. Cell 72, 43-53.
22. Lesch, K.P., Bengel, D., 1995. Neurotransmitter reuptake mechanisms. Pharmacol. Pathophysiol. CNS Drugs 4, 302-322.
23. Masuo, Y., Montagne, M.N., Pelaprat, D., Scherman, D., Rostene, W., 1990. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density. Brain. Res. 520, 6-13.
24. 3H]-Dopamine over a wide range of concentrations by rat striatal preparations. Biochem. Pharmacol. 35, 4065-4071.
25. Missale, C., Castelletti, L., Govoni, S., Spano, P.F., Trabucchi, M., Hanbauer, I., 1985. Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J. Neurochem. 45, 51-56.
26. Naudon, L., Leroux-Nicollet, I., Costentin, J., 1992. Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems. Brain. Res. 593, 32-38.
27. Near, J.A., Bigelow, J.C., Wightman, R.M., 1988. Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J. Pharmacol. Exp. Ther. 245, 921-927.
28. Nicholson, C., 1995. Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum. Biophys. J. 68, 1699-1715.
29. 3H]-DA uptake and autoxidation in rat striatal slices. Neurodegeneration 'in press'.
30. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, Academic Press, New York.
31. Pellmar, T.C., 1995. Use of brain slices in the study of free-radical actions. J. Neurosci. Meth. 59, 93-98.
32. Pelton, E.W., Kimelberg, H.K., Shipherd, S.V., Bourke, R.S., 1981. Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture. Life Sci. 28, 1655-1663.
33. Petrali, E.H., Boulton, A.A., Dyck, L.E., 1979. Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat. Neurochem. Res. 4, 633-642.
34. Ramassamy, C., Girbe, F., Christen, Y., Costentin, J., 1995. Peroxidation of synaptosomes alters the dopamine uptake complex but spares the exocytotic release of dopamine. Neurodegeneration 4, 155-160.
35. Rudnick, G., Clarck, J., 1993. From synapse to vesicle. The reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta 1144, 249-263.
36. Schuldiner, S., 1994. A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 62, 2067-2077.
37. Schwarting, R.K.W., Huston, J.P., 1996. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50, 275-331.
38. Shaskan, E.G., Snyder, S.H., 1970. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharmacol. Exp. Ther. 175, 404-418.
39. Stamford, J.A., Kruk, Z.L., Millar, J., 1986. In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density. Brain. Res. 373, 85-91.
40. 3H] Nisoxetine: a new radioligand for norepinephrine uptake sites in brain. Eur. J. Pharmacol. 191, 239-243.
41. Uhl, G., 1992. Neurotransmitter transporter (plus): a promising new gene family. Trends Neurosci. 15, 265-268.
42. Ungerstedt, U., 1968. 6-hydroxydopamine-induced degeneration of control monoamine neurons. Eur. J. Pharmacol. 5, 107-110.
43. Urwyler, S., Von Wartburg, J.P., 1981. Uptake and metabolism of catechol-oxidase. Biochem. Pharmacol. 30, 2777-2785.